Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
755.57
+21.00 (2.86%)
At close: May 12, 2025, 4:00 PM
759.00
+3.43 (0.45%)
After-hours: May 12, 2025, 7:59 PM EDT
Eli Lilly Stock Forecast
Stock Price Forecast
According to 19 professional analysts, the 12-month price target for Eli Lilly stock ranges from a low of $700 to a high of $1,190. The average price target of $1,005 forecasts a 33.02% increase in the stock price over the next year.
Price Target: $1,005.05 (+33.02%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eli Lilly stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 10 | 11 |
| Buy | 9 | 8 | 8 | 7 | 7 | 7 |
| Hold | 2 | 2 | 2 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 22 | 22 | 20 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $1,100 → $1,050 | Strong Buy | Maintains | $1,100 → $1,050 | +38.97% | May 2, 2025 |
| HSBC | HSBC | Strong Buy → Sell Downgrades $1,150 → $700 | Strong Buy → Sell | Downgrades | $1,150 → $700 | -7.35% | Apr 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $975 | Buy | Initiates | $975 | +29.04% | Apr 22, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $973 → $928 | Strong Buy | Maintains | $973 → $928 | +22.82% | Apr 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $1,146 → $1,124 | Buy | Maintains | $1,146 → $1,124 | +48.76% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
60.06B
from 45.04B
Increased by 33.34%
Revenue Next Year
72.00B
from 60.06B
Increased by 19.87%
EPS This Year
23.18
from 11.71
Increased by 97.93%
EPS Next Year
29.92
from 23.18
Increased by 29.09%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 63.8B | 79.4B | 96.6B | ||
| Avg | 60.1B | 72.0B | 84.6B | ||
| Low | 57.2B | 66.8B | 76.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 41.6% | 32.2% | 34.2% | ||
| Avg | 33.3% | 19.9% | 17.5% | ||
| Low | 27.0% | 11.3% | 6.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.13 | 36.44 | 45.85 | ||
| Avg | 23.18 | 29.92 | 37.19 | ||
| Low | 21.11 | 26.55 | 30.60 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 114.6% | 57.2% | 53.3% | ||
| Avg | 97.9% | 29.1% | 24.3% | ||
| Low | 80.3% | 14.5% | 2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.